Patent Assignment
Reel/Frame 036242/0362
Assignment of Assignor's Interest
Recorded: 2015-07-31
Pages: 8
Assignor
VTVX HOLDINGS II LLC
Executed: 2015-07-29
Assignee
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKS PKWY, HIGH POINT, NORTH CAROLINA, 27265
Covered Properties
(45)
Substituted Imidazoles, Their Preparation and Use
Patent:
6,908,926 →
Application:
09/548,081 →
New Compounds, Their Preparation and Use
Patent:
6,972,294 →
Application:
09/551,740 →
Peroxisome Proliferator-Activated Receptor (Ppar) Active Vinyl Carboxylic Acid Derivatives
Compounds, Their Preparation and Use
Substituted Hexahydropyrrolo[1,2-a]Pyrazines, Octahydropyrido[1,2-a]-Pyrazines and Decahydropyrazino[1,2-A]Azepines
Peroxisome Proliferator Acticvated Receptor-Active Arylene Acetic Acid Derivatives
Combination Therapy Using an 11BETA-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders
Bissulfonamide Compounds as Agonists of GALR1, Compositions, and Methods of Use
Novel Piperazines
Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
Phenoxy Acetic Acids as Ppar Delta Activators
Novel Medicaments
Novel Compounds, Their Preparation and Use
Benzothiazoles Having Histamine H3 Receptor Activity
6- (4-Cyclopropylpiperazin-1-Yl) -2 ' -Methyl- [3, 4 ' ] -Bipyridine and Its Use as a Medicament
3-(L,3-Benzodioxol-5-Yl)-6-(4-Cyclopropylpiperazin-L-Yl)-Pyridazine, Its Salts and Solvates and Its Use as Histamine H3 Receptor Antagonist
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis
Pharmaceutical Use of Substituted Amides
Heterocyclic H3 Antagonists
Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Substituted Imidazo[1,2-B]Pyridazine Derivatives, Pharmaceutical Compositions, and Methods of Use as Beta-Secretase Inhibitors
Phenyl Propionic Acids as Ppar Delta Activators
Phenoxy Acetic Acids as Ppar Delta Activators
Adamantyl Benzamide Derivatives
Substituted Thiazol-2-Ylamine Derivatives, Pharmaceutical Compositions, and Methods of Use as 11-Beta HSD1 Modulators
Substituted Isoquinoline Derivatives, Pharmaceutical Compositions, and Methods of Use as Beta-Secretase Inhibitors
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Phenoxy Acetic Acids as Ppar Delta Activators
Novel Medicaments
Benzothiazoles Having Histamine H3 Receptor Activity
Phenoxy Acetic Acids as Ppar Delta Activators
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Compounds That Modulate Oxidative Stress
Phenoxy Acetic Acids and Phenyl Propionic Acids as Ppar Delta Agonists
Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Use of a Ppar-Delta Agonist for Treating Muscle Atrophy
Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof
Application:
62/085,875 →
Inhibitors of Hexokinase and Methods of Use Thereof
Application:
62/171,051 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Aug 9, 2013
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0793 →
Notice of Release of Security Interest in Patents for Reel/Frame 030982/0793
Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: HIGH POINT PHARMACEUTICALS, LLC
Reel/Frame 032621/0867 →
Security Interest
Feb 26, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0029 →
Change of Name
Jul 30, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: VTVX HOLDINGS II LLC
Reel/Frame 036236/0159 →
Release of Security Interest
Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS I LLC
Reel/Frame 036254/0792 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 036254 Frame: 0792. Assignor(S) Hereby Confirms the Assignment.
Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036675/0399 →
Security Interest
Apr 18, 2018
From: VTV THERAPEUTICS LLC
To: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Reel/Frame 045969/0774 →
Release of Security Interest
Jan 27, 2021
From: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
To: VTV THERAPEUTICS LLC
Reel/Frame 055133/0214 →